| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Repligen Corporation (RGEN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. RGEN is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 99.0K | $12.53M | - | |
| Dir | 91.8K | $11.62M | - | |
| CEO | 54.2K | $6.87M | - | |
| VP | 20.1K | $2.54M | - | |
| Other | 8.5K | $1.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 14, 2017 | Benjamin Howard | VP Business Development | Sale+OE | 12,729 | $35.34 | $449,835.22 | -27.3% | |
| Mar 21, 2017 | Dawes Karen A63 | Director | Sale+OE | 2,521 | $34.12 | $86,016.77 | -2.6% | |
| Mar 20, 2017 | Benjamin Howard | VP Business Development | Sale+OE | 12,216 | $34.62 | $422,953.81 | -18.2% | |
| Mar 20, 2017 | Ryan Thomas F Jr66 | Director | Sale+OE | 4,000 | $34.83 | $139,321.20 | -31.8% | |
| Mar 17, 2017 | Snodgres Jon59 | Chief Financial Officer | Sale+OE | 1,909 | $34.91 | $66,646.05 | -7.4% | |
| Nov 28, 2016 | Hunt Anthony75 | Chief Executive Officer | Sell | 5,000 | $33.12 | $165,613.00 | -6.8% | |
| Sep 14, 2016 | Ryan Thomas F Jr66 | Director | Sell | 2,700 | $32.58 | $87,978.69 | -22.3% | |
| Jun 30, 2016 | Ryan Thomas F Jr66 | Director | Sell | 5,000 | $26.60 | $133,010.00 | -29.3% | |
| Jun 28, 2016 | Ryan Thomas F Jr66 | Director | Sale+OE | 10,000 | $24.59 | $245,888.00 | -36.9% | |
| May 11, 2016 | Benjamin Howard | VP Business Development | Sell | 2,889 | $26.72 | $77,199.28 | -13.4% |